美国三州甲肝暴发相关成人病例中甲肝疫苗接种指征的流行情况
该研究从三个受人际传播甲肝暴发严重影响的外州随机抽取成人暴发相关甲肝病例,评估其是否具有ACIP推荐的甲肝疫苗接种指征、接种状态及流行病学关联病例是否接受暴露后预防。结果显示74.1%的病例有记录的ACIP接种指征,但不足20%的流行病学关联病例接受了暴露后预防。结论认为需提高提供者对ACIP儿童和成人甲肝疫苗接种及暴露后预防建议的认知与依从性。
要点
- 74.1%的暴发相关成人甲肝病例有记录的ACIP甲肝疫苗接种指征。
- 不足20%的流行病学关联病例接受了暴露后预防。
- 需加强提供者对ACIP甲肝疫苗接种和暴露后预防建议的认知与依从。
核心结论
- 需提高提供者对ACIP儿童和成人甲肝疫苗接种及暴露后预防建议的认知与依从性,以阻止当前人际传播甲肝暴发并预防未来类似暴发。
研究设计与样本
- 从三个受人际传播甲肝暴发严重影响的外州随机抽取成人暴发相关甲肝病例进行评估。
主要发现
- 74.1%的病例有记录的ACIP甲肝疫苗接种指征。
- 不足20%的流行病学关联病例接受了暴露后预防。
关键数值与推荐
- 74.1%的暴发相关成人甲肝病例有记录的ACIP甲肝疫苗接种指征。
- 不足20%的流行病学关联病例接受了暴露后预防。
临床怎么用
- 提供者应识别成人甲肝疫苗接种指征并依从ACIP建议进行接种和暴露后预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Safe and effective hepatitis A vaccines have been recommended in the United States for at-risk adults since 1996; however, adult vaccination coverage is low. METHODS: Among a random sample of adult outbreak-associated hepatitis A cases from three states that were heavily affected by person-to-person hepatitis A outbreaks, we assessed the presence of documented Advisory Committee on Immunization Practices (ACIP) indications for hepatitis A vaccination, hepatitis A vaccination status, and whether cases that were epidemiologically linked to an outbreak-associated hepatitis A case had received postexposure prophylaxis (PEP). RESULTS: Overall, 74.1% of cases had a documented ACIP indication for hepatitis A vaccination. Fewer than 20% of epidemiologically linked cases received PEP. CONCLUSIONS: Efforts are needed to increase provider awareness of and adherence to ACIP childhood and adult hepatitis A vaccination and PEP recommendations in order to stop the current person-to-person hepatitis A outbreaks and prevent similar outbreaks in the future.
引用
- Hofmeister MG, Weng MK, Thoroughman D, et al. Prevalence of indications for adult hepatitis A vaccination among hepatitis A outbreak-associated cases, Three US States, 2016-2019. Vaccine. 2021. PMID: 34598818. doi:10.1016/j.vaccine.2021.09.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。